Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases
โ Scribed by Sevil Kamali; Ayse Cefle; Mehmet Sayarlioglu; Ahmet Gul; Murat Inanc; Lale Ocal; Orhan Aral; Meral Konice
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 182 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w
The effect of intravenous immunoglobulin (IVIG) on various laboratory values was measured immediately before and after completion of serial monthly infusions of IVIG (2 g/kg) or an equal volume of placebo over 3-12 months, in 46 patients with neuromuscular diseases participating in controlled trials